Association between variants in IDE-KIF11-HHEX and plasma amyloid β levels
- 31 January 2012
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 33 (1) , 199.e13-199.e17
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Health
- National Institute on Aging (R37-AG15473, P01-AG07232)
- Paul B. Beeson Career Development Award (K23AG034550)
This publication has 13 references indexed in Scilit:
- GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 CarriersNeuron, 2007
- Genetic variants in a haplotype block spanningIDE are significantly associated with plasma A?42 levels and risk for Alzheimer diseaseHuman Mutation, 2004
- Enhanced Proteolysis of β-Amyloid in APP Transgenic Mice Prevents Plaque Formation, Secondary Pathology, and Premature DeathNeuron, 2003
- Genetic variation in a haplotype block spanningIDE influences Alzheimer diseaseHuman Mutation, 2003
- Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivoProceedings of the National Academy of Sciences, 2003
- Familial Alzheimer Disease Among Caribbean HispanicsArchives of Neurology, 2002
- Genetic case-control association studies - correcting for multiple testingHuman Genetics, 2001
- Evidence for Genetic Linkage of Alzheimer's Disease to Chromosome 10qScience, 2000
- Degradation of Soluble Amyloid β-Peptides 1–40, 1–42, and the Dutch Variant 1–40Q by Insulin Degrading Enzyme from Alzheimer Disease and Control BrainsNeurochemical Research, 2000
- The APOE-∊4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and HispanicsJAMA, 1998